Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.

Microengineered Liver Tissues for Drug Testing

Open access

Abstract

Drug-induced liver injury (DILI) is a leading cause of drug attrition. Significant and well-documented differences between animals and humans in liver pathways now necessitate the use of human-relevant in vitro liver models for testing new chemical entities during preclinical drug development. Consequently, several human liver models with various levels of in vivo-like complexity have been developed for assessment of drug metabolism, toxicity, and efficacy on liver diseases. Recent trends leverage engineering tools, such as those adapted from the semiconductor industry, to enable precise control over the microenvironment of liver cells and to allow for miniaturization into formats amenable for higher throughput drug screening. Integration of liver models into organs-on-a-chip devices, permitting crosstalk between tissue types, is actively being pursued to obtain a systems-level understanding of drug effects. Here, we review the major trends, challenges, and opportunities associated with development and implementation of engineered liver models created from primary cells, cell lines, and stem cell-derived hepatocyte-like cells. We also present key applications where such models are currently making an impact and highlight areas for improvement. In the future, engineered liver models will prove useful for selecting drugs that are efficacious, safer, and, in some cases, personalized for specific patient populations.

Overview

Integrity signals

Registry

Crossref · 10.1177/2211068214566939

Cites

210 of 210 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 210 references

Research works printed but not linked: 2

  1. Guguen-Guillouzo, 2010, General Review on In Vitro Hepatocyte Models and Their Applications, Methods Mol. Biol., 640, 1, 10.1007/978-1-60761-688-7_1 · DOI · Paper page
  2. Berger, D. R., Ware, B. R., Davidson, M. D., et al. Enhancing the Functional Maturity of iPSC-Derived Human Hepatocytes via Controlled Presentation of Cell-Cell Interactions In Vitro. Hepatology, in press.

Cited by

See all 117

Metadata

Authors
Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R.
Affiliations
Colorado State University (US)
Corresponding author
Khetani, Salman R.
Venue
SLAS Technology
Publisher
Elsevier BV
Published
2015-06
Volume
20
Issue
3
Pages
216-250
ISSN
2472-6303 (ISSN-L)
OpenAlex
W2114732687
Cited by
116
References
210
Citations by year
2026: 4 · 2025: 7 · 2024: 1 · 2023: 7 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 14 · 2017: 11 · 2016: 18 · 2015: 8
FWCI
1.32
Type
journal article
Language
en
Open access
Licence
Locations
  • SLAS TECHNOLOGY (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
drug-induced liver injury, organ-on-a-chip, hepatocyte-like cells, stem cell-derived hepatocytes, primary hepatocytes, cell lines, drug metabolism, drug toxicity, drug screening, microenvironment control, miniaturization, personalized drug testing
MeSH terms
Animals, Drug Evaluation, Preclinical, Humans, Liver, Miniaturization, Stem Cells, Hepatocytes, Tissue Engineering, Systems Biology, Chemical and Drug Induced Liver Injury, Lab-On-A-Chip Devices, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microengineered Liver Tissues for Drug Testing. https://app.cochat.ai/papers/10.1177/2211068214566939
The paper
Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R. (2015). Microengineered Liver Tissues for Drug Testing. SLAS Technology. https://doi.org/10.1177/2211068214566939

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.